3093.1 Community and Clinical Factors in Substance Use

Monday, November 8, 2010: 10:30 AM - 12:00 PM
Oral
This session will look at substance abuse from 3 perspectives, the associations between alcohol use and drug abuse; a specific program and treatment to intervene in narcotic overdose; and clinical tools for assessing the severity of drug abuse. These perspectives allow for determination of community-related risk factors for substance abuse, immediate lifesaving interventions, and abuse severity measures that can guide ongoing treatment.
Session Objectives: Describe the associations between alcohol use and drug abuse Evaluate use of Naloxone for opioid overdose Describe use of clinical tools to assess level of substance abuse
Moderator:
Sean Haley, PhD, MPH
Panelists:
Katherine J. Karriker-Jaffe, PhD , Ning Rosenthal, MD, PhD, MPH , Courtney Pierce, MPH , Tripathi Rajavashisth, PhD and Lucy Napper, PhD

10:30am
Neighborhood disadvantage amplifies risk of drug problems for residents with a family history of alcohol problems
Katherine J. Karriker-Jaffe, PhD
        
10:48am
Effect of perceived neighborhood norms on binge drinking and illicit drug use among non-Hispanic Asian American and White adults in the United States
Ning Rosenthal, MD, PhD, MPH, Susan D. Cochran, PhD, MS, William McCarthy, PhD and Vickie M. Mays, PhD, MSPH
     
11:06am
Assessing the implementation of opioid overdose education and naloxone distribution in Massachusetts: The Intranasal Naloxone and Prevention EDucation's Effect on OverDose (INPEDE OD) Study
Alexander Walley, MD, MSc, Courtney Pierce, MPH, Al Ozonoff, PhD, Holly Hackman, MD, MPH, Sarah Ruiz, MSW, Barry Callis, MSW, Daniel Hovelson and Andy Epstein, RN, MPH
     
11:24am
Decreased Prevalence of Diabetes in Marijuana Users: Data from NHANES III
Tripathi Rajavashisth, PhD, Magda Shaheen, MD, PhD, MPH, Deyu Pan, MS, Satyesh Sinha, PhD, Juan Ortega, BS and Theodore Friedman, MD, PhD
11:42am
Validity of the Addiction Severity Index in a substance abuse treatment sample with psychiatric comorbidity
Lucy Napper, PhD, Dennis G. Fisher, PhD, Grace L. Reynolds, DPA, Safia Baig, BA and Bridget Rogala, MPH, CHES
     

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: Epidemiology

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Alcohol, Tobacco, and Other Drugs
<< Previous Session | Next Session >>